ACTIVE SUBSTANCE / INN

ATORVASTATIN CALCIUM

Brand name(s): ATORVALIQ, ATORVASTATIN CALCIUM, LYPQOZET, LIPITOR, LIPTRUZET, CADUET, AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA091650
NDA213260
ACTIVE SUBSTANCE
Atorvastatin Calcium
REGULATORS
FDA
SPONSORS / MAH
PHARMACIA, PHARMOBEDIENT, CMP DEV LLC
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ATORVASTATIN CALCIUMANDA091650DR REDDYS LABS LTDPrescription
LIPTRUZETNDA200153ORGANONDiscontinued
ATORVASTATIN CALCIUMANDA217634STRIDES PHARMADiscontinued
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUMANDA200465MYLANPrescription
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUMANDA200465MYLANDiscontinued
CADUETNDA021540PHARMACIAPrescription
ATORVALIQNDA213260CMP DEV LLCPrescription
LYPQOZETANDA206084PHARMOBEDIENTPrescription
LIPITORNDA020702UPJOHNPrescription

FULL INTELLIGENCE ON ATORVASTATIN CALCIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →